HR 5736

This bill, the Penicillin Allergy Verification and Evaluation Act (PAVE Act), aims to improve healthcare for Medicare beneficiaries by requiring healthcare providers to verify penicillin allergy diagnoses during initial preventive physical examinations and annual wellness visits. The bill seeks to address the issue of widespread, potentially inaccurate penicillin allergy labels, which can negatively impact patient outcomes and increase healthcare costs. It mandates a process for verifying these allergies through testing and evaluation, ultimately promoting more appropriate antibiotic use and better patient care.